SciClone Pharmaceuticals
SciClone profit up 4.3% to RMB622.7m in H1 2021
Its revenue rose 14.7% to RMB1.3b in the same period.
SciClone profit up 4.3% to RMB622.7m in H1 2021
Its revenue rose 14.7% to RMB1.3b in the same period.
Resource Center
Read Here
Advertise
Sign Up
Event News
Only one of two leading firms achieves 80% of their digital transformation project targets.
